Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARMADILLO trial of local-field versus prophylactic irradiation chemoradiotherapy for cT1bN0M0 esophageal cancer
jRCTs031200067Phase 3Active, not recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of fluorouracil and cisplatin in esophageal cancer (2 arms), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Primary endpoint: major progression-free survival. Started Jul 2020; status: active, not recruiting.
02
Drugs
fluorouracilcisplatin
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on jRCTs031200067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200067.